Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer

Cancer

Volumn 117, Issue 16, 2011, Pages 3670-3681

  Nagelkerke, Anika ^a   Mujcic, Hilda ^b,c   Bussink, Johan ^a   Wouters, Bradly G ^b,c   Van Laarhoven, Hanneke W M ^a   Sweep, Fred C G J ^a   Span, Paul N ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

breast neoplasms; DC LAMP; hypoxia; metastasis; TSC403

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 3; MESSENGER RNA; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER SURVIVAL; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; LAMP3 GENE; LYMPH NODE; METASTASIS; MOUSE; NONHUMAN; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; OXYGEN; PROGNOSIS;

EID: 80051526098     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25938     Document Type: Article

References (36)

1. de Saint-Vis B, Vincent J, Vandenabeele S, et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity. 1998; 9: 325-336. (Pubitemid 28462753)
2. Kanao H, Enomoto T, Kimura T, et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res. 2005; 65: 8640-8645. (Pubitemid 41377350)
3. Ozaki K, Nagata M, Suzuki M, et al. Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Res. 1998; 58: 3499-3503. (Pubitemid 28376538)
4. Fukuda M,. Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem. 1991; 266: 21327-21330. (Pubitemid 121000182)
5. Fukuda M,. Biogenesis of the lysosomal membrane. Subcell Biochem. 1994; 22: 199-230.
6. Saitoh O, Wang WC, Lotan R, Fukuda M,. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992; 267: 5700-5711.
7. Carlsson SR, Fukuda M,. The lysosomal membrane glycoprotein lamp-1 is transported to lysosomes by two alternative pathways. Arch Biochem Biophys. 1992; 296: 630-639.
8. Brown JM, Giaccia AJ,. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998; 58: 1408-1416. (Pubitemid 28193601)
9. Hall EJ,. Molecular biology in radiation therapy: the potential impact of recombinant technology on clinical practice. Int J Radiat Oncol Biol Phys. 1994; 30: 1019-10128.
10. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol. 1998; 48: 149-156. (Pubitemid 28423786)
11. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P,. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996; 56: 4509-4515. (Pubitemid 26330463)
12. Sundfor K, Lyng H, Rofstad EK,. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer. 1998; 78: 822-827. (Pubitemid 28418321)
13. Chan DA, Giaccia AJ,. Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev. 2007; 26: 333-339. (Pubitemid 47101666)
14. Mujcic H, Rzymski T, Rouschop KM, et al. Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3. Radiother Oncol. 2009; 92: 450-459.
15. Wouters BG, Koritzinsky M,. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer. 2008; 8: 851-864.
16. Rouschop KM, van den Beucken T, Dubois L, et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest. 2010; 120: 127-141.
17. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW, Schutte M,. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res. 2007; 5: 195-201. (Pubitemid 46424000)
18. Hollestelle A, Nagel JH, Smid M, et al. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2009; 121: 53-64.
19. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM,. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005; 97: 1180-1184. (Pubitemid 41258223)
20. Span PN, Waanders E, Manders P, et al. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol. 2004; 22: 691-698. (Pubitemid 41095073)
21. Koritzinsky M, Magagnin MG, van den Beucken T, et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 2006; 25: 1114-1125. (Pubitemid 43372124)
22. Treilleux I, Blay JY, Bendriss-Vermare N, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res. 2004; 10: 7466-7474. (Pubitemid 39561754)
23. Calabro A, Beissbarth T, Kuner R, et al. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer. Breast Cancer Res Treat. 2009; 116: 69-77.
24. Chen JW, Murphy TL, Willingham MC, Pastan I, August JT,. Identification of two lysosomal membrane glycoproteins. J Cell Biol. 1985; 101: 85-95. (Pubitemid 15061257)
25. Feizi T,. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 1985; 314: 53-57. (Pubitemid 15142022)
26. Fukuda M,. Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells. Biochim Biophys Acta. 1985; 780: 119-150.
27. Heffernan M, Yousefi S, Dennis JW,. Molecular characterization of P2B/LAMP-1, a major protein target of a metastasis-associated oligosaccharide structure. Cancer Res. 1989; 49: 6077-6084. (Pubitemid 19274173)
28. Laferte S, Dennis JW,. Purification of two glycoproteins expressing beta 1-6 branched Asn-linked oligosaccharides from metastatic tumour cells. Biochem J. 1989; 259: 569-576. (Pubitemid 19111695)
29. Hunziker W, Geuze HJ,. Intracellular trafficking of lysosomal membrane proteins. Bioessays. 1996; 18: 379-389. (Pubitemid 126599963)
30. Sawada R, Lowe JB, Fukuda M,. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem. 1993; 268: 12675-12681. (Pubitemid 23182432)
31. Kannagi R,. Carbohydrate antigen sialyl Lewis a-its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J. 2007; 30: 189-209. (Pubitemid 47235445)
32. Kannan K, Stewart RM, Bounds W, et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. Cell Immunol. 1996; 171: 10-19. (Pubitemid 26349119)
33. Takada A, Ohmori K, Takahashi N, et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun. 1991; 179: 713-719.
34. Koike T, Kimura N, Miyazaki K, et al. Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA. 2004; 101: 8132-8137. (Pubitemid 38698066)
35. Bussink J, Kaanders JH, van der Kogel AJ,. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol. 2003; 67: 3-15. (Pubitemid 36575463)
36. Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ, Bussink J,. Molecular aspects of tumour hypoxia. Mol Oncol. 2008; 2: 41-53.